Moderna, Inc. (NASDAQ:MRNA) today announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the ...

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results this Friday before market hours. Here’s what ...

Moderna stock has delivered a strong 70.9% gain over the past year, but the longer track record and current valuation checks ...

Moderna MRNA is set to report second-quarter 2026 earnings on July 31, before the opening bell. The Zacks Consensus Estimate ...

Moderna (NASDAQ:MRNA | MRNA Price Prediction) enters a critical six-day stretch with Q2 earnings due July 31, and an FDA ...

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first ...

French pharmaceutical company Sanofi has filed lawsuits against Pfizer and Moderna, claiming the companies used patented technology in their COVID-19 ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The story of the biotech company Moderna almost reads like a ...

Moderna said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market. In a ...

Moderna (MRNA) closed at $55.63 in the latest trading session, marking a +2.89% move from the prior day. This change outpaced ...

CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook.

Other news has also lifted sentiment. The company's recent investor day also included a surprise announcement that it is gearing up to develop an in vivo CAR-T candidate. Success with this endeavor ...